BioCardia, Inc.
BCDA
$1.14
$0.043.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.59% | 14.62% | -24.48% | -19.63% | -10.81% |
| Total Depreciation and Amortization | -80.00% | -75.00% | -70.59% | -36.84% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.54% | -33.09% | -25.10% | 0.00% | 38.79% |
| Change in Net Operating Assets | -44.46% | 67.82% | 266.67% | 80.71% | -577.50% |
| Cash from Operations | -2.63% | 35.96% | -25.69% | -5.75% | -31.44% |
| Capital Expenditure | -500.00% | 100.00% | 66.67% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -500.00% | 100.00% | 66.67% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -87.18% | -5.77% | -8.33% | -85.54% | -97.10% |
| Repurchase of Common Stock | -40.71% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -300.00% | 25.28% | 77.42% | 82.22% | 89.43% |
| Cash from Financing | -130.40% | -2.34% | -5.93% | -85.76% | -111.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.07% | 22.74% | -93.43% | -823.38% | -249.59% |